Jeffrey Johnson
Internal Medicine · Provo, UTNPI 1285692400
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,677 and has fallen 63.5% since, to $612 in 2021.
Across 205 payments — averaging $12.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$364
- AbbVie$361
- Pfizer$274
- AstraZeneca$202
- Novo Nordisk$194
- Sanofi-aventis U.S. LLC$158
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,625100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 27 | $364 |
| AbbVie(2 entities) | 20 | $361 |
| Pfizer | 43 | $274 |
| AstraZeneca | 16 | $202 |
| Novo Nordisk | 15 | $194 |
| Sanofi-aventis U.S. LLC | 11 | $158 |
| Lilly USA, LLC | 20 | $149 |
| Amgen | 9 | $144 |
| Medtronic | 2 | $124 |
| Astellas Pharma US Inc | 8 | $113 |
| Daiichi Sankyo Inc. | 5 | $105 |
| Johnson & Johnson | 6 | $100 |
| Novartis | 3 | $50 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Abbott | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| Amarin Pharma, Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| BD | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,631 in reported general payments places this provider in the 80th percentile of 496 internal medicine providers in Utah.
Other internal medicine in Provo
- Bryce SwensonProvo$9K
- Lawrence NobuharaProvo$9K
- Richard OlsenProvo$6K
- James HawkesProvo$5K
- Russell RhoadesProvo$5K
- Willard DereSalt Lake City$4.7M
- Kenneth SchaecherWest Valley City$333K
- Steven CallSpringville$178K
- James ChamberlainSalt Lake City$106K
- Alexander PastuszakSalt Lake City$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.